Literature DB >> 10586054

Commitment to the CD4 lineage mediated by extracellular signal-related kinase mitogen-activated protein kinase and lck signaling.

L L Sharp1, S M Hedrick.   

Abstract

The development of T cells results in a concordance between the specificity of the TCR for MHC class I and class II molecules and the expression of CD8 and CD4 coreceptors. Based on analogy to simple metazoan models of organ development and lineage commitment, we sought to determine whether extracellular signal-related kinase (Erk) mitogen-activated protein (MAP) kinase pathway signaling acts as an inductive signal for the CD4 lineage. Here, we show that, by altering the intracellular signaling involving the Erk/MAP kinase pathway, T cells with specificity for MHC class I can be diverted to express CD4, and, conversely, T cells with specificity for MHC class II can be diverted to express CD8. Furthermore, we find that activation of the src-family tyrosine kinase, p56lck is an upstream mediator of lineage commitment. These results suggest a simple mechanism for lineage commitment in T cell development.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10586054

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

Review 1.  PI3K/AKT signaling and systemic autoimmunity.

Authors:  Rahul K Patel; Chandra Mohan
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

2.  Itk derived signals regulate the expression of Th-POK and controls the development of CD4 T cells.

Authors:  Jianfang Hu; Qian Qi; Avery August
Journal:  PLoS One       Date:  2010-01-26       Impact factor: 3.240

3.  Inositol (1,4,5) trisphosphate 3 kinase B controls positive selection of T cells and modulates Erk activity.

Authors:  Ben G Wen; Mathew T Pletcher; Masaki Warashina; Sun Hui Choe; Niusha Ziaee; Tim Wiltshire; Karsten Sauer; Michael P Cooke
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-02       Impact factor: 11.205

4.  B-Raf is required for positive selection and survival of DP cells, but not for negative selection of SP cells.

Authors:  Tara J Dillon; Maho Takahashi; Yanping Li; Srilatha Tavisala; Susan E Murray; Amy E Moran; David C Parker; Philip J S Stork
Journal:  Int Immunol       Date:  2013-01-18       Impact factor: 4.823

Review 5.  Onco-immunomodulatory properties of pharmacological interference with RAS-RAF-MEK-ERK pathway hyperactivation.

Authors:  Thomas Yul Avery; Natalie Köhler; Robert Zeiser; Tilman Brummer; Dietrich Alexander Ruess
Journal:  Front Oncol       Date:  2022-07-27       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.